C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2009
11/10/2009	CA2272843C Broad-spectrum delta-endotoxins
11/10/2009	CA2219963C Interleukin-18-receptor proteins
11/05/2009	WO2009135118A2 Lyme disease vaccine
11/05/2009	WO2009134962A2 Claudin-4 binding peptides, compositions and methods of use
11/05/2009	WO2009134952A2 Potent conjugates and hydrophilic linkers
11/05/2009	WO2009134891A2 Immunomodulating compositions and methods of use thereof
11/05/2009	WO2009134805A2 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009	WO2009134738A1 Responses to immunizations in rheumatoid arthritis patients treated with a cd20 antibody
11/05/2009	WO2009134711A1 Humanized anti-factor d antibodies and uses thereof
11/05/2009	WO2009134428A2 Methods and compositions for modulating angiogenesis and pericyte composition
11/05/2009	WO2009134370A2 Methods and products relating to gsk3 beta regulation
11/05/2009	WO2009133951A1 Anti-perspiration antigen monoclonal antibody
11/05/2009	WO2009133521A2 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders
11/05/2009	WO2009133452A1 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1
11/05/2009	WO2009133208A1 Improved fibronectin-based binding molecules and uses thereof
11/05/2009	WO2009133103A1 Inhibitors of gm-csf and il-17 for therapy
11/05/2009	WO2009132876A1 Cytotoxic immunoglobulin
11/05/2009	WO2009132821A1 Interleukin (il-21) binding proteins and methods of making and using same
11/05/2009	WO2009112245A9 Antibody against the csf-1 r
11/05/2009	WO2009109635A3 Novel antigen binding dimer-complexes, methods of making and uses thereof
11/05/2009	WO2009108372A3 Antibodies as t cell receptor mimics, methods of production and uses thereof
11/05/2009	WO2009102509A3 Vaccines and diagnostics for ehrlichia chaffeensis
11/05/2009	WO2009086411A3 Negative mimic antibody for use as a blocking reagent in bnp immunoassays
11/05/2009	WO2009086072A3 Therapy of rituximab-refractory rheumatoid arthritis patients
11/05/2009	WO2009082243A3 Glycosyltransferases, polynucleotides encoding these and methods of use
11/05/2009	WO2009029883A3 Methods and compositions for modulating t cells
11/05/2009	WO2008110379A8 Monoclonal antibodies for treatment of cancer
11/05/2009	WO2008060705A8 Anti-dll4 antibodies and methods using same
11/05/2009	US20090276863 Protein formulations comprising s1-5
11/05/2009	US20090275738 Use of A33 antigens and jam-it
11/05/2009	US20090275737 Immunogenic compositions and uses thereof
11/05/2009	US20090275736 NMDAR Biomarkers for Diagnosis and Treatment of Traumatic Brain Injury and Other Disorders
11/05/2009	US20090275735 Monoclonal antibodies to human ctla-8 (il-17a)
11/05/2009	US20090275734 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
11/05/2009	US20090275644 Novel adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
11/05/2009	US20090275636 Picornavirus and uses thereof
11/05/2009	US20090275516 Compounds and method for modulating inflammatory reactions
11/05/2009	US20090275512 Compositions and methods for treating cardiovascular disease and myocardial infarction with dipeptidyl peptidase inhibitors or b type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation
11/05/2009	US20090275504 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
11/05/2009	US20090275498 Novel peptides
11/05/2009	US20090275126 Antibodies against insulin-like growth factor i receptor and uses thereof
11/05/2009	US20090275125 Human T1R2 Taste Receptor Nucleic Acids and Cells Containing These Nucleic Acids
11/05/2009	US20090275124 Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
11/05/2009	US20090275077 Methods of Obtaining Optically Active Epoxides and Vicinal Diols from Styrene Oxides
11/05/2009	US20090275068 Method of determining chymase activity with secretory leukocyte protease inhibitor
11/05/2009	US20090275066 Immobilization of membrane porteins onto supports via an amphiphile
11/05/2009	US20090275056 untagged antigen is used in conjunction with a polyclonal antibody to isolate cells recognizing the antigen; for cancers, autoimmune or inflammatory disorders
11/05/2009	US20090275055 Monoclonal Antibodies Specific to Denatured Human Class I Leucocyte Antigens
11/05/2009	US20090275050 14273 receptor, a novel G-protein coupled receptor
11/05/2009	US20090275049 EphA4 POLYPEPTIDE HAVING A NOVEL ACTIVITY AND USE THEREOF
11/05/2009	US20090275048 Anti-acharan sulfate antibody and its application
11/05/2009	US20090275041 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/05/2009	US20090275030 Cell calcification suppressing proteins, and genes of the proteins
11/05/2009	US20090275021 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
11/05/2009	US20090275020 Traceability of Cellular Cycle Anomalies Targeting Oncology and Neurodegeneration
11/05/2009	US20090275013 Method for preparing a monoclonal antibody to the common epitope of nonstructural NSs protein of watermelon silver mottle virus and assay for detection of serological related species in the genus tospovirus with the monoclonal antibody
11/05/2009	US20090274719 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/05/2009	US20090274717 Genes and proteins, and their use
11/05/2009	US20090274715 Tick chitinase
11/05/2009	US20090274713 Cross-linkers and their uses
11/05/2009	US20090274710 Trans-membrane-antibody induced inhibition of apoptosis
11/05/2009	US20090274708 Recombinant Toxin Fragments
11/05/2009	US20090274707 Anti-IL-12 Antibodies, Nucleic Acids Encoding Antibodies, and Methods of Production
11/05/2009	US20090274706 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009	US20090274705 Il-13 binding agents
11/05/2009	US20090274704 Anti-staphylococcus aureus antibodies
11/05/2009	US20090274702 Method of treatment and Agents useful for same
11/05/2009	US20090274701 Chlamydia pneumoniae polynucleotides and uses thereof
11/05/2009	US20090274700 Il-31 receptor antibodies
11/05/2009	US20090274699 Ul16 binding protein 4
11/05/2009	US20090274697 Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
11/05/2009	US20090274696 Methods for treating inflammation
11/05/2009	US20090274694 Cytokine receptor zcytor17 multimers
11/05/2009	US20090274692 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
11/05/2009	US20090274691 Use of CD25 binding molecules in steroid-resistant patients
11/05/2009	US20090274690 Stimulating remyelination of central nervous system axons by administering a monoclonal antibody characterized by their ability to bind structures and cells within the central nervous system, including oligodendrocytes; including neural dysfunction caused by spinal cord injury
11/05/2009	US20090274689 For improving clinical outcome in focal ischemic stroke in a mammal by increasing cerebral blood flow and/or reducing infarct size in absence of removal of the arterial obstruction
11/05/2009	US20090274688 Antibodies to OPGL
11/05/2009	US20090274680 Human Phospholipases
11/05/2009	US20090274666 B7-h1, a novel immunoregulatory molecule
11/05/2009	US20090274653 Interleukin-2 mutants with reduced toxicity
11/05/2009	US20090274649 Bispecific Antibody Point Mutations for Enhancing Rate of Clearance
11/05/2009	US20090274647 Immunotherapeutic Formulations with Interleukin-2-Neutralizing Capacity
11/05/2009	US20090274620 Hybridoma Cell Line G250 and its use for Producing Monoclonal Antibodies
11/05/2009	US20090274619 Tumor vasculature markers and methods of use therof
11/05/2009	CA2723449A1 Methods and compositions for modulating angiogenesis and pericyte composition
11/05/2009	CA2723277A1 Improved fibronectin-based binding molecules and uses thereof
11/05/2009	CA2722696A1 Cross-linkers and their uses
11/05/2009	CA2722137A1 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009	CA2721614A1 Cytotoxic immunoglobulin
11/05/2009	CA2720935A1 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules
11/05/2009	CA2720853A1 Humanized anti-factor d antibodies and uses thereof
11/05/2009	CA2717987A1 Inhibitors of gm-csf and il-17 for therapy
11/05/2009	CA2630510A1 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
11/04/2009	EP2113516A1 Antibodies against C5 inhibiting type II endothelial cell activation
11/04/2009	EP2113255A1 Cytotoxic immunoglobulin
11/04/2009	EP1848458B1 Use of activated polymers for separation of protein and polypeptide multimers
11/04/2009	EP1692180B1 Anti-il-20 antibodies and binding partners and methods of using in inflammation
11/04/2009	EP1682180B1 Antagonist anti-cd40 monoclonal antibodies and methods for their use
11/04/2009	EP1559721B1 Fprl1 ligands and use thereof

1 ... 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 ... 1494